Metrics as of 10/13/2026, 08:52 AM (Berlin time), refresh in progress.
Optimi Health Corp.
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies,…
1D
-4.7%
1W
-16.2%
1M
-21.7%
6M
-49.4%
YTD
-49.5%
1Y
-54.1%
2Y
-23.1%
5Y
-76.6%
10Y
–
Next earnings date
02/02/2027 (in 108 days)
Volatility around earnings
~39% weaker price swings than usual
P/E
-2.52
P/B
1.2
EV/EBITDA
-1.61
RETURN ON EQUITY
-13.6%
NET MARGIN
-1,715.0%
DEBT/EQUITY
0.29
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
74.2%
FLOAT SHARES
2,388,943
AVG. DAILY VOLUME (30D)
54,876
Optimi Health Corp. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Dane Stevens, the company employs around 6 people.
The IPO was on 20/05/2026; the stock trades on NASDAQ under the ticker OPTH.
The next earnings date is 02/02/2027.
Around past earnings, price swings were roughly -39% stronger than usual.
No, Optimi Health currently does not pay a dividend.
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
Clicking "Analyze stock" lets five strategies assess Optimi Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.